Plasma brain natriuretic peptide after long‐term treatment for heart failure in general practice
Open Access
- 10 October 2002
- journal article
- research article
- Published by Wiley
- Vol. 4 (4) , 479-483
- https://doi.org/10.1016/s1388-9842(02)00027-2
Abstract
Aim Plasma brain natriuretic peptide (BNP) concentrations are known to have high sensitivity and specificity in the diagnosis of heart failure in newly symptomatic patients. The relationship of plas...Keywords
This publication has 16 references indexed in Scilit:
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- Neurohumoral Prediction of Benefit From Carvedilol in Ischemic Left Ventricular DysfunctionCirculation, 1999
- Plasma N-Terminal Pro–Brain Natriuretic Peptide and AdrenomedullinCirculation, 1998
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling patternEuropean Heart Journal, 1996
- Assessment and diagnosis of heart failureJournal of Internal Medicine, 1996
- Open access echocardiography in management of heart failure in the communityBMJ, 1995
- Plasma brain natriuretic peptide in assessment of acute dyspnoeaThe Lancet, 1994
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978